Title: The effect of propranolol on gastrointestinal motility and permeability in patients with
cirrhosis and significant portal hypertension
Version: 0 Date: 05 Jun 2024
Reviewer's report:
It is interesting study that beta blocker can enhance bowel motility and improved the bacterial
overgrowth in cirrhosis patients. In terms of gut mobility, beta-blocker is well studied in previous
reports.
This paper not only describes the hemodynamic changes of beta-blockers but also discusses
the changes in gastrointestinal motility and their implications, making it an interesting topic.
However, it lacks explanatory power to draw conclusive findings, and its results diverge
somewhat from previous studies, yet this deviation adds significance to the topic. It suggests that
this area remains relatively unexplored, indicating the potential for further research and deeper
analysis to enhance understanding.
Title: The effect of propranolol on gastrointestinal motility and permeability in patients with
cirrhosis and significant portal hypertension
Version: 0 Date: 05 Jun 2024
Reviewer's report:
It is interesting study that beta blocker can enhance bowel motility and improved the bacterial
overgrowth in cirrhosis patients. In terms of gut mobility, beta-blocker is well studied in previous
reports.
This paper not only describes the hemodynamic changes of beta-blockers but also discusses
the changes in gastrointestinal motility and their implications, making it an interesting topic.
However, it lacks explanatory power to draw conclusive findings, and its results diverge
somewhat from previous studies, yet this deviation adds significance to the topic. It suggests that
this area remains relatively unexplored, indicating the potential for further research and deeper
analysis to enhance understanding.
Please review this paper.
user
Title: The effect of propranolol on gastrointestinal motility and permeability in patients with
cirrhosis and significant portal hypertension
Version: 0 Date: 05 Jun 2024
Reviewer's report:
It is interesting study that beta blocker can enhance bowel motility and improved the bacterial
overgrowth in cirrhosis patients. In terms of gut mobility, beta-blocker is well studied in previous
reports.
This paper not only describes the hemodynamic changes of beta-blockers but also discusses
the changes in gastrointestinal motility and their implications, making it an interesting topic.
However, it lacks explanatory power to draw conclusive findings, and its results diverge
somewhat from previous studies, yet this deviation adds significance to the topic. It suggests that
this area remains relatively unexplored, indicating the potential for further research and deeper
analysis to enhance understanding.
assistant